Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17703315rdf:typepubmed:Citationlld:pubmed
pubmed-article:17703315lifeskim:mentionsumls-concept:C0009324lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C0812445lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C1332821lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C1707170lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C2709058lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C0547047lld:lifeskim
pubmed-article:17703315lifeskim:mentionsumls-concept:C0304604lld:lifeskim
pubmed-article:17703315pubmed:issue12lld:pubmed
pubmed-article:17703315pubmed:dateCreated2007-10-5lld:pubmed
pubmed-article:17703315pubmed:abstractTextUlcerative colitis is characterized by relapsing mucosal inflammation where the lesions include tissue-damaging granulocytes. In addition, T cells and natural killer (NK) cells play important pathophysiologic roles. Chemokines are a large family of peptides that play key roles in the regulation of inflammation. The CXC-chemokines, growth-related oncogene (GRO)-alpha/CXCL1 and interleukin (IL)-8/CXCL8, both recruit neutrophils and possess mitogenic properties, whereas the interferon-dependent CXC-chemokines monokine induced by gamma-interferon (MIG)/CXCL9, interferon-gamma inducible protein of 10 kD/CXCL10, and IFN-inducible T cell alpha chemoattractant/CXCL11 recruit and activate T cells and NK cells.lld:pubmed
pubmed-article:17703315pubmed:languageenglld:pubmed
pubmed-article:17703315pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:citationSubsetIMlld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17703315pubmed:statusMEDLINElld:pubmed
pubmed-article:17703315pubmed:monthDeclld:pubmed
pubmed-article:17703315pubmed:issn0179-1958lld:pubmed
pubmed-article:17703315pubmed:authorpubmed-author:EgestenArneAlld:pubmed
pubmed-article:17703315pubmed:authorpubmed-author:ErjefältJonas...lld:pubmed
pubmed-article:17703315pubmed:authorpubmed-author:CarlsonMarieMlld:pubmed
pubmed-article:17703315pubmed:authorpubmed-author:SangfeltPerPlld:pubmed
pubmed-article:17703315pubmed:authorpubmed-author:BjartellAnder...lld:pubmed
pubmed-article:17703315pubmed:authorpubmed-author:OlinAnders...lld:pubmed
pubmed-article:17703315pubmed:authorpubmed-author:EliassonMette...lld:pubmed
pubmed-article:17703315pubmed:issnTypePrintlld:pubmed
pubmed-article:17703315pubmed:volume22lld:pubmed
pubmed-article:17703315pubmed:ownerNLMlld:pubmed
pubmed-article:17703315pubmed:authorsCompleteYlld:pubmed
pubmed-article:17703315pubmed:pagination1421-7lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:meshHeadingpubmed-meshheading:17703315...lld:pubmed
pubmed-article:17703315pubmed:year2007lld:pubmed
pubmed-article:17703315pubmed:articleTitleThe proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.lld:pubmed
pubmed-article:17703315pubmed:affiliationDepartment of Clinical Sciences Lund, BMC B14, Tornavagen 10, 221 84, Lund, Sweden. Arne.Egesten@med.lu.selld:pubmed
pubmed-article:17703315pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17703315pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:17703315pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2919entrezgene:pubmedpubmed-article:17703315lld:entrezgene
entrez-gene:4283entrezgene:pubmedpubmed-article:17703315lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17703315lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17703315lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17703315lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17703315lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17703315lld:pubmed